monoglyceride lipase; MGL; HU-K5; lysophospholipase homolog; lysophospholipase-like; monoacylglycerol lipase; MAGL (MGLL)
Jump to navigation
Jump to search
Function
- converts monoacylglycerides to free fatty acids & glycerol
- hydrolyzes 2-arachidonoylglycerol (putative endocannabinoid) thus contributing to regulation of pain
- hydrolyzes glycerol monoesters of long-chain fatty acids
- regulates levels of fatty acids involved in
- signal transduction
- cancer cell migration
- tumor invasion[1]
- triglyceride lipolysis, last step
Structure
- homodimer
- belongs to the AB hydrolase superfamily, monoacylglycerol lipase family
Expression
- expressed in adipose tissue, lung, liver, kidney, brain, heart
Pharmacology
- short-term inhibition causes analgesia
- long-term inhibition causes tolerance to endocannabinoids acting on brain cannabinoid receptor CNR1, & a reduction in brain cannabinoid receptor CNR1 activity (putative)
- potential therapeutic target for Alzheimer's disease[2]
More general terms
References
- ↑ 1.0 1.1 UniProt http://www.uniprot.org/uniprot/Q99685.html
- ↑ 2.0 2.1 Kleschevnikov A, Mobley A UCSD Abide team